Preclinical trials

• 
• 
• 

Research activities of «Grindeks» are mainly focused towards the development of:
– cardiovascular medications;
– neurological medications;
– anti-cancer agents;
– antivirual drugs.

Planning and organisation of biomedical pre-clinical trials are performed in the field of the development of new products. In cooperation with the leading scientific research institutions from Latvia and abroad active work is carried out in the development of several new medications. Every year 4–5 research projects are carried out in the company.

Contacts
llmārs Stonāns
Head of the New Product Development department
e-mail: Ilmars.Stonans@grindeks.lv